Beta Bionics, Inc. (BBNX)
NASDAQ · Manufacturing · Surgical & medical instruments & apparatus
$21.51−$0.2500 (−1.15%) on the dayAs of the close; data may be delayed.
BBNX price, last 12 months
Key stats
- Previous close
- $21.76
- Open
- $21.74
- Day range
- $21.25 – $21.98
- 52-week range
- $8.80 – $32.71
- Volume
- 926K
- Avg volume (20 days)
- 1.5M
- Market cap
- $1.2B
Performance
1W−1.7%
1M+11.2%
3M+27.9%
6M+86.7%
YTD−29.4%
1Y−5.4%
vs S&P 500, 1Y−22.2 pts
Technicals and fundamentals
About Beta Bionics, Inc.
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.
- Sector
- Manufacturing
- Industry
- Surgical & medical instruments & apparatus
- Listed on
- NASDAQ
- Market cap
- $1.2B